Rachel McGovern

Rachel McGovern is a seasoned professional in clinical operations with extensive experience in the pharmaceutical industry. Currently serving as the Senior Associate Director - Clinical Development Operations Lead at Boehringer Ingelheim since June 2022, Rachel previously held key positions at Imbrium Therapeutics and Purdue Pharma L.P. as Associate Director of Clinical Operations. Rachel's career began at Bristol-Myers Squibb, where roles included Director of Data Leads and Associate Director, focusing on managing teams within the Oncology therapeutic area and overseeing significant clinical protocols. Rachel holds a Graduate Liberal Studies degree in Science from Wesleyan University and a BS in Biology from Providence College.